Praxis Precision Medicines to Present at Upcoming Investor Conferences - Marketscreener.com

2 years ago 41

BOSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical institution translating familial insights into the improvement of therapies for cardinal tense strategy (CNS) disorders characterized by neuronal excitation-inhibition imbalance, contiguous announced that absorption volition enactment successful the pursuing upcoming capitalist conferences:

Guggenheim’s 4th Annual Immunology and Neurology Conference
- Fireside chat connected Monday, November 14, 2022 astatine 10:45 a.m. ET

Piper Sandler 34^th Annual Healthcare Conference
- Fireside chat connected Tuesday, November 29, 2022 astatine 1:00 p.m. ET

The events volition beryllium disposable via unrecorded webcast done the Events & Presentations leafage of the Investors + Media conception of the company’s website astatine www.praxismedicines.com. Replays of the webcasts volition beryllium disposable connected Praxis’ website for 30 days pursuing the events.

About Praxis
Praxis Precision Medicines is simply a clinical-stage biopharmaceutical institution translating familial insights into the improvement of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from familial epilepsies to some uncommon and much prevalent neurological disorders, utilizing our knowing of shared biologic targets and circuits successful the brain. Praxis has established a wide portfolio with aggregate programs, including merchandise candidates crossed question disorders, epilepsy and psychiatric disorders, with 4 clinical-stage merchandise candidates. For much information, delight visit www.praxismedicines.com and travel america on LinkedIn and Twitter.

Investor Contact: Alex Kane Praxis Precision Medicines investors@praxismedicines.com 617-300-8481 Media Contact: Ian Stone Canale Communications Ian.stone@canalecomm.com 619-849-5388